Evidence map›Paper›PMID 31642809›Full record

ArticleeLife2019

Discovery proteomics in aging human skeletal muscle finds change in spliceosome, immunity, proteostasis and mitochondria.

Ceereena Ubaida-Mohien, Alexey Lyashkov, Marta Gonzalez-Freire, Ravi Tharakan, Michelle Shardell, Ruin Moaddel, Richard D Semba, Chee W Chia, Myriam Gorospe, Ranjan Sen and 1 more

Open access · goldAbstract read
In one paragraph

Article in eLife, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 163 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
163citing papers in PubMed, 2 pooled it
9.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

163 citing papers in PubMed, 2 syntheses or guidelines pooled it, 217 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Trial
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. AAV-mediated FGF21 gene therapy promotes health span extension by whole-body tissue-specific adaptations.Molecular therapy : the journal of the American Society of Gene Therapy · 2026
    Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article

103 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Ceereena Ubaida-MohienIntramural Research Program, National Institute on Aging, National Institutes of Health, Baltimore, United States.
Alexey LyashkovIntramural Research Program, National Institute on Aging, National Institutes of Health, Baltimore, United States.
Marta Gonzalez-FreireIntramural Research Program, National Institute on Aging, National Institutes of Health, Baltimore, United States.
Ravi TharakanIntramural Research Program, National Institute on Aging, National Institutes of Health, Baltimore, United States.
Michelle ShardellIntramural Research Program, National Institute on Aging, National Institutes of Health, Baltimore, United States.
Ruin MoaddelIntramural Research Program, National Institute on Aging, National Institutes of Health, Baltimore, United States.
Richard D SembaJohns Hopkins Medical Institute, Baltimore, United States.
Chee W ChiaIntramural Research Program, National Institute on Aging, National Institutes of Health, Baltimore, United States.
Myriam GorospeIntramural Research Program, National Institute on Aging, National Institutes of Health, Baltimore, United States.
Ranjan SenIntramural Research Program, National Institute on Aging, National Institutes of Health, Baltimore, United States.
Luigi FerrucciIntramural Research Program, National Institute on Aging, National Institutes of Health, Baltimore, United States.ORCID 0000-0002-6273-1613
Institute on Aging · USJohns Hopkins University · US

Funding

Oxidative stress and the pathogenesis of sarcopenia and disability in older womenR01AG027012 · NIA · JOHNS HOPKINS UNIVERSITY · PI SEMBA, RICHARD D · 2005 to 2018
$3.6M
Systemic rejuvenating factors and human aging phenotypes.R01AG057723 · NIA · JOHNS HOPKINS UNIVERSITY · PI SEMBA, RICHARD D · 2018 to 2022
$1.8M
NIA NIH HHS Intramural Research ProgramNIA NIH HHS R01 AG027012NIA NIH HHS R01 AG057723NIH HHS NIH R01 AG027012NIH HHS NIH R01 AG057723
6 · The paper itself

Abstract

A decline of skeletal muscle strength with aging is a primary cause of mobility loss and frailty in older persons, but the molecular mechanisms of such decline are not understood. Here, we performed quantitative proteomic analysis from skeletal muscle collected from 58 healthy persons aged 20 to 87 years. In muscle from older persons, ribosomal proteins and proteins related to energetic metabolism, including those related to the TCA cycle, mitochondria respiration, and glycolysis, were underrepresented, while proteins implicated in innate and adaptive immunity, proteostasis, and alternative splicing were overrepresented. Consistent with reports in animal models, older human muscle was characterized by deranged energetic metabolism, a pro-inflammatory environment and increased proteolysis. Changes in alternative splicing with aging were confirmed by RNA-seq analysis. We propose that changes in the splicing machinery enables muscle cells to respond to a rise in damage with aging.

Indexed as

ProteostasisAdultAgedAged, 80 and overAgingFemaleHumansMaleMiddle AgedMitochondriaMuscle CellsMuscle, SkeletalProteomeProteomicsSpliceosomesYoung AdultProteomeagingepidemiologyglobal healthhumanhuman biologymedicinemitochondriaproteomicsproteostasisskeletal musclespliceosome

Identifiers

PMID31642809
PMCPMC6810669
OpenAlexW2981995922

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.